Skip to navigation Skip to content

Participe en una prueba clínica

Sin la participación de personas con esclerosis múltiple, sería imposible desarrollar nuevos y mejores tratamientos, y otras intervenciones.

Share

Nos esforzamos por traducir cada vez más contenido al español, pero algunos de los enlaces incluidos aquí van a páginas en inglés. Si usa el traductor de su navegador, tenga en cuenta que es posible que la traducción no sea exacta.

Pruebas clínicas cercanas

¿Tiene interés en las pruebas clínicas? Simplemente busque por estado, tipo de esclerosis múltiple o palabra clave, y vea qué está sucediendo en su zona.

v
  1. Clinical Trial: Treadmill Walking and Anxiety in Persons with MS

    Anxiety is common in MS, yet we know very little about how it can be managed. This study examines the effect of a single bout of moderate-intensity aerobic exercise on state anxiety in persons with MS who have elevated anxiety levels indicative of generalized anxiety disorder ...
  2. Clinical Trial: Gut bacteria and MS

    The Yale-Griffin Prevention Research Center, the Multiple Sclerosis Treatment Center at Griffin Hospital, and Yale University are teaming up to study whether changing the bacteria in the gut can affect the process that leads to the development of multiple sclerosis (MS). This ...
  3. Clinical Trial: Wearables for the Bladder

    This study is testing a solution for bladder problems in females with MS. Pelvic floor (a group of muscles and ligaments that support the bladder, uterus, and bowel) and bladder function will be assessed by a pelvic floor physical therapist as per standard care, and online ...
  4. Clinical Trial: ReCOVER – Clemastine Fumarate in Optic Neuritis

    WE ARE ACTIVELY RECRUITING PEOPLE EXPERIENCING A SUSPECTED OR DIAGNOSED ACUTE OPTIC NEURITIS IN A PREVIOUSLY UNAFFECTED EYE. VISUAL SYMPTOMS MUST BE WITHIN THE PAST 3 WEEKS AND THE PATIENT MUST BE STEROID NAIVE.  ReCOVER aims to assess the effect of Clemastine Fumarate as a...
  5. Research Study: Palm cooling after exercise

    This study measures and compares the amount of heat lost through the hands before, during, and after exercise, from two identical workouts. One workout sees persons with multiple sclerosis (MS) engage in palm cooling as they wear specialized gloves, while the other does no...
  6. Clinical Trial: Wheelchair Exercise-training for people with MS

    The purpose of this study is to examine the feasibility and initial efficacy of a novel exercise training program for people with MS who use wheelchairs. This intervention was developed with input from people with MS. If you choose to participate in this study, you will be ran...
  7. Clinical Trial: A phase 1 safety study of ANK-700 in people with relapsing-remitting MS

    Study Rationale: Multiple sclerosis (MS) is a neurological disease that causes damage to the brain and spinal cord, and steadily worsens over time. As the central nervous system (CNS) controls most body functions, people living with MS can experience a wide range of symptoms. ...
  8. Clinical Trial: A Telehealth tDCS Approach to Decrease Cannabis Use

    Researchers at NYU Langone Health, Multiple Sclerosis Comprehensive Care Center, are recruiting women with RRMS (ages 21 to 65) who regularly use any cannabis product (e.g., marijuana, edibles, vaping) and who wish to reduce cannabis use. The research study will be a one-month...
  9. Clinical Trial: An Online Physical Activity Lifestyle Program

    The Health Promotion and Rehabilitation Lab at the University of Illinois Urbana-Champaign is attempting to increase sustainable physically active lifestyle in this 8-week online program. To be eligible, participants must be,   18 years or older,   diagnosed with all su...
  10. Clinical Trial: Antioxidant for fatigue in MS and other studies

    Clinical Trial: Antioxidant for fatigue in MS Type of MS : ALL MS TYPES, RRMS PPMS, SPMS Treatment mode of action: ORAL Number of Subjects: 60 Medication: Mitoquinone (MitoQ, an antioxidant) Institution: Oregon Health Science University and Veterans Affairs Portland...
  11.  |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 

Share


© 2023 La Sociedad Nacional de Esclerosis Múltiple es una entidad sin fines de lucro de tipo 501(c)3 y exenta de impuestos. Su número de identificación (EIN por su sigla en inglés) es 13-5661935.